⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL9716420 | 0.87 | ALOX5 (0.48) | — | |
| Diallyl Sulfide SCHEMBL2520685 | 0.80 | ALOX5 (0.73) | — | |
| Diallyl Sulfide SCHEMBL45800 | 0.78 | — | — | |
| Diallyl Sulfide SCHEMBL4346718 | 0.78 | — | — | |
| Diallyl Sulfide SCHEMBL14764035 | 0.78 | ALOX5 (1.00) | — | |
| SCHEMBL453366 | 0.75 | — | — | |
| Diallyl Sulfide SCHEMBL11665328 | 0.74 | — | — | |
| Diallyl Sulfide SCHEMBL9280151 | 0.74 | — | — | |
| Diallyl Sulfide SCHEMBL7130288 | 0.74 | — | — | |
| Diallyl Sulfide SCHEMBL5912153 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1363628-A2 | DRUGS FOR SEX DYSFUNCTIONS | NICOX S.A. (FR) | 2003-11-26 | — | — | EP | claimed |
| US-20030171393-A1 | Drugs for sex dysfunctions | NICOX S.A. (FR) | 2003-09-11 | — | — | US | claimed |
| WO-2002011706-A2 | DRUGS FOR SEX DYSFUNCTIONS | NICOX S.A. (FR) | 2002-02-14 | — | — | WO | claimed |
| US-5180400-A | METHOD FOR DYEING KERATINOUS FIBRES USING AN AMINOINDOLE IN COMBINATION WITH A QUINONE DERIVATIVE | L'OREAL (FR) | 1993-01-19 | — | — | US | claimed |
| JP-10264545-A | — | — | None | — | — | JP | disclosed |
| US-20110105597-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2011-05-05 | — | — | US | disclosed |
| US-20100280036-A1 | Modulation of Pathogenicity | QUONOVA, LLC | 2010-11-04 | — | — | US | disclosed |
| US-20090076012-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2009-03-19 | — | — | US | disclosed |
| US-20080214635-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2008-09-04 | — | — | US | disclosed |
| US-20080194588-A1 | Modulation of pathogcnicity | QUONOVA, LLC | 2008-08-14 | — | — | US | disclosed |
| US-20080194607-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2008-08-14 | — | — | US | disclosed |
| US-20080188536-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2008-08-07 | — | — | US | disclosed |
| US-20080188491-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2008-08-07 | — | — | US | disclosed |
| US-20080188535-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2008-08-07 | — | — | US | disclosed |
| US-20080182878-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2008-07-31 | — | — | US | disclosed |
| US-20080176938-A1 | Modulation of pathogenicity | QUONOVA, LLC | 2008-07-24 | — | — | US | disclosed |
| US-20040063765-A1 | Modulation of pathogenicity | 4 SC AG (DE) | 2004-04-01 | — | — | US | disclosed |
| JP-H10264545-A | SHEET FOR HEAT SENSITIVE STENCIL PRINTING, ORIGINAL PLATE FOR HEAT SENSITIVE STENCIL PRINTING, AND ITS MANUFACTURE | NOF CORP | 1998-10-06 | — | — | JP | disclosed |
| EP-0221720-B1 | DIHYDROPYRIDINES | Pfizer Limited (GB) | 1990-06-27 | — | — | EP | disclosed |
| EP-0221720-A2 | Dihydropyridines | Pfizer Limited (GB) | 1987-05-13 | — | — | EP | disclosed |